Computational biology: plus c'est la même chose, plus ça change by Huttenhower, Curtis
 
Computational biology: plus c'est la même chose, plus ça change
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Huttenhower, Curtis. 2011. Computational biology: plus c'est la
même chose, plus ça change. Genome Biology 12(8): 307.
Published Version doi:10.1186/gb-2011-12-8-307
Accessed February 19, 2015 10:48:32 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10576037
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAAs  of  this  writing,  the  average  desktop  computer 
processor contains on the order of one billion transistors. 
Although the growth of the semiconductor industry has 
frequently  been  compared  to  that  of  high-throughput 
sequencing, the field perhaps shares a number of deeper 
traits with this year’s joint International Conference on 
Intelligent  Systems  for  Molecular  Biology  (ISMB)  and 
European Conference on Computational Biology (ECCB). 
Bioinformatics, like data storage, is becoming ever more 
adept at organizing tremendous quantities of information - 
not  simply  producing  data,  but  intelligently  cataloging 
and interpreting it. Chip design, like biology, requires not 
simply the presence of billions of independent parts, but 
their careful orchestration into an information-process-
ing unit through controlled interactions. And like quantum 
computing, goals such as translational genomics remain 
tantalizingly on the horizon, close enough to see their 
potential  but  not  yet  realized  in  day-to-day  practice. 
These three topics appeared consistently throughout the 
ISMB/ECCB  conference,  which  hosted  nearly  2,000 
attendees and was immediately preceded by the accom-
panying  Student  Council  Symposium  (SCS).  Here,  I 
summarize the themes, highlights, and events of these 
two  of  the  many  joint  conferences  organized  by  the 
International Society for Computational Biology (ISCB).
The data deluge: still keeping our heads above water
Bioinformatics  has  been  dealing  with  an  exponential 
growth  in  data  since  its  coalescence  as  a  field  in  the 
1980s, making the Senior Scientist Award keynote with 
which  Michael  Ashburner  closed  the  conference 
particularly appropriate. This retrospective by the ‘father 
of  ontologies  in  biology’,  to  quote  the  introduction  by 
ISCB president Burkhard Rost, detailed the remarkable 
expansion  of  computational  biology  since  Ashburner’s 
start  as  a  Cambridge  undergraduate  50  years  ago.  His 
tongue-in-cheek career summary included the point at 
which international data transfer rates on the emerging 
ARPANET became more practical than hard-copy print-
outs  (apparently  19.2  kbaud);  the  initial  £13  million 
funding of the European Bioinformatics Institute in res-
ponse to a half-page proposal; and of course the founding 
of the Gene Ontology Consortium by a small, enthusiastic 
group of researchers at the 6th ISMB in 1998. Ashburner 
concluded  by  urging  scientists  to  communicate  their 
research openly to the community and to the public at 
large.  The  degree  to  which  bio  informatics  already  em-
braces this philosophy was, fortunately, evident in ISMB’s 
Technology Track, which highlighted popular open tools 
throughout  the  conference,  particularly  mainstays  of 
sequence analysis including Ensembl, the University of 
California Santa Cruz’s Genome Browser, and Galaxy.
While the conference was ended by the Senior Scientist 
Award, it was opened by a group of over 80 scientists at 
the  beginnings  of  their  careers,  specifically  the  ISCB 
Student  Council  Symposium.  This  student-run  sympo-
sium  has  accompanied  ISMB/ECCB  since  2005  and 
annually  features  presentations,  posters,  and  faculty 
keynotes focused on graduate student research. Both the 
SCS Best Presentation award to Amit Deshwar and its 
Best  Poster  award  to  Benjamin  Kwan  highlighted  the 
need for novel algorithms as data continue to grow, both 
in  gene  expression  repositories  and  as  whole-genome 
sequences. The Symposium was anchored by Ivet Bahar’s 
senior faculty keynote, which demonstrated several ways 
in  which  she  has  used  massive  data  to  discover  new 
protein folds and to enrich our overall understanding of 
structural  genomics.  The  areas  of  functional  and 
structural  genomics  both  include  some  of  the 
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with  the  historical  perspective  of  Ashburner’s 
keynote,  these  presentations  emphasized  the 
continuing power of new algorithms in combination 
with ever-increasing data availability.
Nowhere at ISMB was this more evident than in high-
throughput sequencing, an area highlighted by over 25 
talks and by the HiTSeq special interest group meeting. 
Transcriptomics and RNA sequencing were of particular 
interest  this  year,  with  a  comprehensive  description  of 
developments in sequencing and other high-throughput 
technologies  provided  by  Janet  Thornton’s  ECCB  10th 
anniversary  keynote.  Thornton,  a  self-professed  ‘data 
junkie’, characterized the EBI’s goal as understanding life 
from  individual  biomolecules  through  to  interaction 
networks,  information  processing  circuits,  predictive 
simulations, and their impacts on human health. The talk 
mentioned the EBI’s 12 petabytes of diverse information - 
and, amazingly, that these data continue to double every 
5 months. Thornton described the breadth of these data 
and  detailed  methods  for  predictive  biochemical 
modeling of specific ligase enzyme families. She closed 
by  emphasizing  that  current  methods  only  scratch  the 
surface  of  what  is  possible.  Fundamental  questions 
regard  ing  the  evolution  of  the  human  reactome 
(complete reaction catalog) and the composition of a core 
reactome necessary for all life remain unanswered but, 
for the first time, are perhaps within reach.
Biological networks: unraveling a tangled web
Two  years  ago  during  the  2009  ISMB  Overton  Prize 
keynote, Trey Ideker jokingly suggested that his predic-
tions in a 2006 review regarding the future of biological 
network analysis had, like most futurology, been perhaps 
a bit optimistic. This year’s conference proved him more 
prescient  than  was  apparent,  as  many  of  the  most 
important questions in computational biology continue 
to  revolve  around  network  models.  This  was  apparent 
from the very beginning of ISMB/ECCB 2011, which was 
opened by Bonnie Berger’s keynote on the critical roles of 
good algorithms in massive data mining. Berger outlined 
three challenges addressed by recent work: compressive 
genomics for rapid data retrieval, medical genomics for 
establishing clinically reliable signal-to-noise levels, and 
network alignment for understanding interactome evolu-
tion. Each of these represents a cutting-edge appli  ca  tion 
of  computer  science  to  biology  not  possible  without 
sufficient data, appropriate network models, and efficient 
algorithms, all areas of active research.
A significant feature of bioinformatic network analysis, 
however, is that it enables not only novel network mining 
algorithms, but also new ways of formulating biological 
systems  and  modeling  functional,  molecular,  and 
evolutionary mechanisms. The first was demonstrated by 
Chad Myers in one of two SCS junior faculty keynotes, in 
which  he  explained  experimental  and  computational 
techniques for the construction of a genome-wide genetic 
interaction  network  in  Saccharomyces  cerevisiae.  In  a 
related collaboration presented during the ISMB High-
lights track, Philip Kim focused on the specific biological 
roles of intrinsically disordered proteins, demonstrating 
that  these  fall  into  classes  of  flexible,  constrained,  and 
non-conserved  disorder.  In  yet  another  example  of 
creative  network  modeling,  Maureen  Stolzer  discussed 
recent  research  on  the  evolution  of  multi-domain 
proteins, using co-occurrence analysis to show that even 
well-studied  families  such  as  the  kinases  acquire 
functionality through domain shuffling. Although these 
are only a few of the network construction and investi-
gation topics introduced at ISMB, they emphasize that 
although the area has been a perennial favorite of bio-
informatics,  it  continues  to  be  a  rich  source  both  of 
computational methods and of biological understanding.
Correspondingly,  in  what  has  been  described  as  a 
‘systems  biology  tour  de  force’,  Louis  Serrano  unified 
these  themes  in  his  keynote  on  the  comprehensive 
investigation of metabolism in Mycoplasma pneumoniae. 
He described the motivation for this study as an effort to 
reproduce  a  microbe  in  silico;  it  is  not  yet  possible  to 
simulate  an  entire  human  being,  but  a  tiny  obligate 
parasite might be feasible. An initial automated metabolic 
reconstruction recovered over 80% of the final reaction 
catalog, but the remainder was unraveled using literature 
curation. These reactions were validated (and improved) 
using flux balance analysis, which was in turn validated 
(and improved again) using nuclear magnetic resonance 
and mass spectrometry metabolomics. Placing computa-
tional and experimental techniques back to back at every 
step  has  provided  detailed  genomic,  transcriptional, 
interaction, and metabolic maps of this organism - but 
other studies continue today on post-translational regu-
lation,  stochastic  regulation,  and  proteomics.  Serrano 
pointed out that over 25% of M. pneumoniae’s proteome 
still  remains  poorly  characterized,  and  presentations 
throughout  the  conference  and  at  the  preceding 
Automated  Function  Prediction  meeting  provided 
additional  methods  for  molecular  function  prediction. 
The  importance  of  coupling  computational  work  with 
detailed experimental validation was also clear, however. 
Adding to the emphasis on this area’s significance, Sara 
Berthoumieux’s  work  on  improving  metabolic  network 
reconstruction by accounting for the incompleteness of 
high-throughput datasets garnered her the Ian Lawson 
Van Toch Memorial Award for the best student paper.
Translational bioinformatics on the horizon
Only  a  year  after  the  New  York  Times  ran  a  skeptical 
article proclaiming, ‘Consumers slow to embrace the age 
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fact squarely in the midst of a transition to translational 
genomic applications. It is of necessity a slow and careful 
transition, however, as emphasized by Alfonso Valencia 
in his ISCB Fellow keynote detailing bioinformatic chal-
len  ges  in  personalized  cancer  treatment.  He  distin-
guished between the high-throughput methods at which 
computational biology excels, including protein docking, 
chromatin mapping, and evolutionary phylostratification, 
and  the  low-noise,  high-reliability  inferences  vital  to 
treatment in the clinic. As he stated, these are difficult to 
produce quickly or automatically - but contrary to the 
New  York  Times’  expectation,  successful  studies  have 
resulted in improved, targeted treatments for individual 
leukemia  patients.  Echoing  Ashburner’s  call  for  open 
research, Valencia pointed out that the absolute certainty 
required  for  validation  of  clinical  recommendations  is 
best achieved by collaboration, data sharing, and consoli-
dation throughout the community.
Methodological  talks  throughout  the  conference 
covered  areas  in  which  researchers  continue  to  bridge 
these  remaining  gaps.  The  Biological  Literature,  Infor-
mation  and  Knowledge  (BioLINK)  special  session  in 
particu  lar featured presentations on data integration and 
interoperability across the computational, biological, and 
medical fields, and it was strikingly the first year in which 
these have converged to the point of including the session 
within  ISMB  itself.  Ankur  Parikh  and  Wei  Wu,  joint 
recipients  of  the  JBI  best  translational  bioinformatics 
paper award, reached a further level of specificity with 
TREEGL, a novel algorithm for reconstruction of human 
breast cancer cellular lineages from sparse gene expres-
sion data. Looking at the earliest stages of translation, my 
junior faculty keynote at the SCS discussed techniques 
for  characterizing  metabolic  function  in  the  microbial 
communities of the human microbiome, dysfunctions of 
which  are  increasingly  implicated  in  disease.  Trans-
lational research topics were pervasive and spanned from 
molecular mechanisms at the level of individual amino 
acids to the categorization of patient phenotypes in the 
clinic, reflecting the field’s aspiration and expectation of 
extending lifespans and saving lives.
The  ISCB’s  Overton  Prize  is  awarded  annually  to  an 
early-  to  mid-career  investigator  who  has  contributed 
significantly  to  the  field  of  computational  biology  and 
who  exemplifies  the  research,  education,  and  service 
goals of the Society as a whole. Olga Troyanskaya, this 
year’s recipient, presented a keynote that brought together 
the  data  integration  methodology,  biological  network 
modeling, and translational applications highlighted by 
ISMB. Troyanskaya described a research path that began 
almost 10 years ago with the first work on integrative bio-
informatics in the simple model S. cerevisiae, proceeded 
into  its  systems  biology  and  that  of  more  complex 
metazoan models, and continues today with the goal of 
automatically  reconstructing  complete  pathway  activity 
maps specific to individual tissues and cellular lineages in 
human disease. Summarizing her own work and the state 
of the field, Troyanskaya concluded that most of compu-
tational  biology’s  achievements  may  still  not  reach  the 
clinic within 5 years - but we should expect to see them 
there within the next decade.
We  are  frequently  shown  that  bioinformatics  and 
processor design share the mixed blessing of exponential 
growth,  but  we  are  less  often  reminded  of  a  corollary 
shared feature: no matter how much we know today, it 
will be outdated tomorrow. Learning from tremendous 
data  collections,  understanding  biological  network 
models,  and  bridging  molecular  biology  with  human 
health  have  been  themes  both  of  the  field  and  of  the 
ISMB/ECCB  conferences  since  their  inception.  The 
knowledge and results accumulated within these areas, 
however, have also grown exponentially; as suggested by 
the  title  of  this  report,  even  the  decades-old  field  of 
sequence analysis continues to grow through both new 
data and novel methodology. We look forward to new 
surprises at next year’s ECCB in Basel, Switzerland, and 
ISMB in Long Beach, California.
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